United Therapeutics stock price
유나이티드 테라퓨틱스NASDAQ:UTHR · Nasdaq · HealthcareToday's signals · MACD bullish cross
Signal details →United Therapeutics last closed at $541.70 (-5.19%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is 18.9×. Its overall grade ranks 223 of 739 stocks in Healthcare.
About this company
United Therapeutics last closed at $541.70 (-5.19%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 223/739
Valuation grade F
Related stocks
- MedtronicCompetitor
이식형/호흡기 치료 시장에서 경쟁
- BayerCompetitor
폐동맥고혈압(PAH) 치료제 경쟁
- Johnson & JohnsonCompetitor
PAH 및 희귀질환 치료제 경쟁
ETFs holding this stock
Simplify Health Care ETF · Inspire Faithward Mid Cap Momentum ETF · Invesco Dynamic BioTech & Genome ETF
Details →About United Therapeutics
- What technical signals does United Therapeutics (UTHR) have?
- United Therapeutics current technical signals: MACD bullish cross.
- Is United Therapeutics a cup-and-handle pattern?
- No. United Therapeutics has no valid Cup signal right now.
- What published figures are available for United Therapeutics?
- Market cap: $23.32B. Trailing 12 months PER: 18.9×. Latest quarter PBR: 3.88×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about United Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).